Seminars in liver disease
-
Seminars in liver disease · Nov 2014
ReviewRecent advances in the prevention of hepatocellular carcinoma recurrence.
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. Early-stage HCC can be curatively treated, but the recurrence rate remains high. ⋯ Several new lines of evidence have emerged to support the use of novel antiviral agents for preventing the recurrence of virus-related HCC after curative treatment. In this review, the authors provide a thorough overview of the various adjuvant treatments that have been attempted or are being considered for trial.